Ação Alterar Data
Adma Biologics USD 266.12M 26.8M 2026-09
BioCryst Pharmaceuticals USD 13.74M 7.68M 2026-09
Eli Lilly USD 18.19B 1.4B 2026-09
Halozyme Therapeutics USD 132.61M 4.52M 2026-09
Insmed USD 163.95M 21.56M 2026-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
MannKind USD 48.47M 4.05M 2026-09
Merck USD 6.16B 43M 2026-09
Novavax USD 18.5M 8.49M 2026-09
Novo Nordisk DKK 51.35B 8.5B 2026-03
Pfizer USD 10.02B 77M 2026-09
Sanofi EUR 24.12B 620M 2026-06